KNBIF (Kane Biotech) Accounts Payable: $0.00 Mil (As of Mar. 2026)


What is Kane Biotech Accounts Payable?

Kane Biotech KNBIF -8.37% Accounts Payable is $0.00 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Kane Biotech's Accounts Payable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Kane Biotech's quarterly Accounts Payable increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.50 Mil) but then declined from Dec. 2025 ($0.50 Mil) to Mar. 2026 ($0.00 Mil).

Kane Biotech's annual Accounts Payable increased from Dec. 2023 ($0.33 Mil) to Dec. 2024 ($0.83 Mil) but then declined from Dec. 2024 ($0.83 Mil) to Dec. 2025 ($0.50 Mil).

Kane Biotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Accounts Payable Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.44 0.33 0.83 0.50

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.76 0.00 0.50 0.00

Kane Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.00 Mil mean?
Kane Biotech (KNBIF) has a Accounts Payable of $0.00 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kane Biotech and its competitors.
Is Kane Biotech's Accounts Payable too high?
Kane Biotech's current Accounts Payable is $0.00 Mil.
How does Kane Biotech's Accounts Payable compare to VRTX and REGN?
Kane Biotech's Accounts Payable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kane Biotech and its competitors. Kane Biotech's current Accounts Payable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Accounts Payable of $0.00 Mil. The current Accounts Payable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Accounts Payable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.